コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 by pretreatment of monocytes with Ab against P-selectin glycoprotein ligand 1.
2 ted when the bacterium engaged its receptor, P-selectin glycoprotein ligand 1.
3 C(high) monocytes to the CNS is regulated by P-selectin glycoprotein ligand-1.
4 ockade of P-selectin or its leukocyte ligand P-selectin glycoprotein ligand-1.
5 d by monoclonal antibodies to L-selectin and P-selectin glycoprotein ligand-1.
6 ce deficient in the major P-selectin ligand, P-selectin glycoprotein ligand-1.
8 f initial treatment with the soluble form of P-selectin glycoprotein ligand-1, a soluble ligand for P
10 d and rejected grafts express high levels of P-selectin glycoprotein ligand 1 and glycosylated CD43.
11 edominant E-selectin ligands on NK cells are P-selectin glycoprotein ligand-1 and protease-resistant
12 heres (MSs) were conjugated with recombinant P-selectin glycoprotein ligand-1 and systemically inject
13 uding CD43, CD44, CD45, CD93, CD162 (PSGL-1; P-selectin glycoprotein ligand 1), and the surface-attac
14 E-selectin-mediated migration of Tc1 cells, P-selectin glycoprotein ligand-1 appears to be the sole
15 These results indicate that P-selectin and P-selectin glycoprotein ligand-1 are not required for le
17 at utilizes sialyl Lewis x (sLe(x))-modified P-selectin glycoprotein ligand 1 as a receptor for infec
18 or with a supporting role for the P-selectin/P-selectin glycoprotein ligand 1 axis, followed by (2) f
19 ltransferases, C2GnT (Core2 transferase), or P-selectin glycoprotein ligand-1 between HL60var and typ
20 irectly shown to contribute to high-affinity P-selectin glycoprotein ligand-1 binding by P-selectin.
21 played on O-linked glycans, akin to those on P-selectin glycoprotein ligand-1, but distinct from the
22 e reduced tethering to the L-selectin ligand P-selectin glycoprotein ligand-1, but rolling velocity o
23 ectin-bearing microspheres or neutrophils on P-selectin glycoprotein ligand-1 by force decreased bond
25 tethering of these microspheres or cells to P-selectin glycoprotein ligand-1 by three transport mech
26 trafficking, and P-selectin and its ligand, P-selectin glycoprotein ligand-1, can modulate hemostasi
27 on an array of protein scaffolds, including P-selectin glycoprotein ligand-1, CD43, and CD44 (render
28 ther administration of a soluble recombinant P-selectin glycoprotein ligand-1 chimera (rPSGL-Ig) in c
29 significantly higher numbers of recombinant P-selectin glycoprotein ligand-1-conjugated MSs adhered
30 m-diameter microspheres with the recombinant P-selectin glycoprotein ligand-1 construct 19.ek.Fc.
31 O treatment reduced intragraft expression of P-selectin glycoprotein ligand-1, CX(3)CL1, CCL19, CCL20
32 pus was induced in female wild-type (WT) and P-selectin glycoprotein ligand-1 deficient (Psgl-1(-/-))
33 neutrophils roll over FLIPRs in a P-selectin/P-selectin glycoprotein ligand-1-dependent manner, retri
35 /hematopoietic cell E-/L-selectin ligand and P-selectin glycoprotein ligand-1) from hematopoietic cel
36 og of the naturally occurring binding ligand P-selectin glycoprotein ligand 1 fused to a human fragme
37 which contained two E-selectin ligands, the P-selectin glycoprotein ligand-1 glycoform "CLA," and CD
38 ty regulates thrombosis in a P-selectin- and P-selectin glycoprotein ligand-1-independent manner and
39 f infection and is mediated by chemokine- or P-selectin glycoprotein ligand-1-induced inside-out sign
40 D49d and CD49e, as well as to P-selectin and P-selectin glycoprotein ligand 1, inhibited basophil rol
41 vealed that CLP-2 homing involves P-selectin/P-selectin glycoprotein ligand 1 interactions, pertussis
44 n-associated antigen-1 activation that links P-selectin glycoprotein ligand-1 ligation to integrin ac
45 tern to LNs, neutrophils used L-selectin and P-selectin glycoprotein ligand-1, macrophage-1 Ag and LF
47 eefold increase in O-linked glycosylation of P-selectin glycoprotein ligand-1 on the surface of leuko
48 rvival times of P-selectin dissociating from P-selectin glycoprotein ligand 1 or from an antibody in
49 ls through engagement of the selectin ligand P-selectin glycoprotein ligand-1 or the chemokine recept
50 urements of L- and P-selectin complexed with P-selectin glycoprotein ligand-1 or their respective ant
52 teraction between P-selectin and its ligand (P-selectin glycoprotein ligand-1) plays a role in adenos
53 pendent of the mucin-like molecules CD43 and P-selectin glycoprotein ligand-1, previously implicated
54 ECA-452-reactive and nonreactive isoforms of P-selectin glycoprotein ligand 1 (PSGL-1) and can tether
59 ocytophilum are linked to bacterial usage of P-selectin glycoprotein ligand 1 (PSGL-1) as a receptor
60 d with neutrophil activation, rolling ligand P-selectin glycoprotein ligand 1 (PSGL-1) expression, as
63 residues in the leukocyte adhesion molecule P-selectin glycoprotein ligand 1 (PSGL-1) is required fo
65 cule 1 failed to ameliorate ileitis, whereas P-selectin glycoprotein ligand 1 (PSGL-1) neutralization
66 ding of P-selectin on activated platelets to P-selectin glycoprotein ligand 1 (PSGL-1) on the microvi
68 nine, and interleukin 15, adhesion molecules P-selectin glycoprotein ligand 1 (PSGL-1), intercellular
69 e many candidate ligands for selectins, only P-selectin glycoprotein ligand 1 (PSGL-1), which also ac
71 ce probe to test the leukocyte adhesion bond P-selectin glycoprotein ligand 1 (PSGL-1)-P-selectin, we
79 mic endothelial cells and lost expression of P-selectin glycoprotein ligand 1 (PSGL-1, CD162) and L-s
80 tion of T cells marked by down-regulation of P-selectin glycoprotein ligand 1 (PSGL-1; also known as
81 king antibodies against either P-selectin or P-selectin glycoprotein ligand-1 (PSGL-1) alone inhibite
82 selectin ligands are expressed on human HCs, P-selectin glycoprotein ligand-1 (PSGL-1) and a speciali
83 to human neutrophils requires expression of P-selectin glycoprotein ligand-1 (PSGL-1) and alpha1-3-f
84 CLA epitope on T cells has been described on P-selectin glycoprotein ligand-1 (PSGL-1) and associated
85 etween oligosaccharides from human leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) and from zona
88 antigen-1, and CXCR4 but lower expression of P-selectin glycoprotein ligand-1 (PSGL-1) and of L-selec
89 eshold shear to support leukocyte rolling on P-selectin glycoprotein ligand-1 (PSGL-1) and other vasc
91 lection fluorescence/epi intensity, and that P-selectin glycoprotein ligand-1 (PSGL-1) and the integr
93 face expression of CXCR2 and less pronounced P-selectin glycoprotein ligand-1 (PSGL-1) begin to incre
95 glycosulfopeptide binding site (2-GSP-6) on P-selectin glycoprotein ligand-1 (PSGL-1) but not for a
97 the off-rate of P-selectin interacting with P-selectin glycoprotein ligand-1 (PSGL-1) decreased with
98 ed antigen (CLA), a specialized glycoform of P-selectin glycoprotein ligand-1 (PSGL-1) defined by mon
99 this study, we show that mice deficient for P-selectin glycoprotein ligand-1 (PSGL-1) develop a more
100 L-selectin interacts with the dimeric mucin P-selectin glycoprotein ligand-1 (PSGL-1) expressed on l
101 n a shear field via bonding of L-selectin to P-selectin glycoprotein ligand-1 (PSGL-1) followed by a
102 (X) (sialyl-Lewis-X) epitope is expressed in P-selectin glycoprotein ligand-1 (PSGL-1) from neutrophi
104 lectin-ligand at the N terminus of leukocyte P-selectin glycoprotein ligand-1 (PSGL-1) in humans and
105 blockade of P- and E-selectins by a soluble P-selectin glycoprotein ligand-1 (PSGL-1) in rat models
107 erminus as an extension of membrane-anchored P-selectin glycoprotein ligand-1 (PSGL-1) inhibited inte
108 inhibited by anti-P-selectin aptamer or anti-P-selectin glycoprotein ligand-1 (PSGL-1) inhibitory ant
122 we found that the E-selectin-binding form of P-selectin glycoprotein ligand-1 (PSGL-1) is expressed o
124 uggested that glycosylation and sulfation of P-selectin glycoprotein ligand-1 (PSGL-1) is required fo
125 Dissociation of bonds between L-selectin and P-selectin glycoprotein ligand-1 (PSGL-1) loaded at a co
126 re mediated through binding of P-selectin to P-selectin glycoprotein ligand-1 (PSGL-1) located on the
127 P-selectin monoclonal antibody (mAb) or anti-P-selectin glycoprotein ligand-1 (PSGL-1) mAb would redu
128 prevention of platelet-leukocyte binding via P-selectin glycoprotein ligand-1 (PSGL-1) may be benefic
135 while P-selectin interacts exclusively with P-selectin glycoprotein ligand-1 (PSGL-1) on leukocytes.
136 we focused on adhesion dynamics that involve P-selectin glycoprotein ligand-1 (PSGL-1) on MM cells an
137 dhesion receptor L-selectin forms bonds with P-selectin glycoprotein ligand-1 (PSGL-1) on other leuko
138 ated platelets through a mechanism involving P-selectin glycoprotein ligand-1 (PSGL-1) on the microve
140 d P- and L-selectin to their natural ligand, P-selectin glycoprotein ligand-1 (PSGL-1) over the predi
145 bond formation rates on their common ligand P-selectin glycoprotein ligand-1 (PSGL-1) under shear fl
146 ics of selectins (P-, L-, and E-selectin) to P-selectin glycoprotein ligand-1 (PSGL-1) via computatio
148 an in vitro flow model and a blocking mAb to P-selectin glycoprotein ligand-1 (PSGL-1) were used to d
149 ts on sialyl Lewis X expression displayed by P-selectin glycoprotein ligand-1 (PSGL-1) with sialylate
150 We tested the hypothesis that deficiency of P-selectin glycoprotein ligand-1 (Psgl-1) would improve
153 is an inducible carbohydrate modification of P-selectin glycoprotein ligand-1 (PSGL-1), a known surfa
154 P-selectin binds to the N-terminal region of P-selectin glycoprotein ligand-1 (PSGL-1), a mucin on le
155 L-selectin bind to the N-terminal region of P-selectin glycoprotein ligand-1 (PSGL-1), a mucin on le
158 enge increase on blood or BAL eosinophils of P-selectin glycoprotein ligand-1 (PSGL-1), a receptor fo
160 id adhesion of beads coated with recombinant P-selectin glycoprotein ligand-1 (PSGL-1), an E-selectin
161 we showed that E-selectin ligand-1 (ESL-1), P-selectin glycoprotein ligand-1 (PSGL-1), and CD44 enco
162 neutrophils roll on P- or E-selectin, engage P-selectin glycoprotein ligand-1 (PSGL-1), and signal ex
163 ophils is linked to neutrophil expression of P-selectin glycoprotein ligand-1 (PSGL-1), as well as si
164 electin binding to its physiological ligand, P-selectin glycoprotein ligand-1 (PSGL-1), both in cell
167 Ethanol (0.3% by volume) had no effect on P-selectin glycoprotein ligand-1 (PSGL-1), L-selectin, o
168 and its leukocyte ligand, a homodimer termed P-selectin glycoprotein ligand-1 (PSGL-1), mediate the e
169 gated the function of the adhesion molecule, P-selectin glycoprotein ligand-1 (PSGL-1), that is upreg
171 do not generate microthrombi in mice lacking P-selectin glycoprotein ligand-1 (PSGL-1), the leukocyte
173 pressing PMPs bridge leukocytes that express P-selectin glycoprotein ligand-1 (PSGL-1), thereby allow
174 lities of selectins and the selectin ligand, P-selectin glycoprotein ligand-1 (PSGL-1), to support te
175 e predominant leukocyte L-selectin ligand is P-selectin glycoprotein ligand-1 (PSGL-1), which display
176 P-selectin blockade is completely absent in P-selectin glycoprotein ligand-1 (PSGL-1)-/- mice or wil
177 intravascular neutrophils through P-selectin/P-selectin glycoprotein ligand-1 (PSGL-1)-mediated bindi
188 rophage adherence promoted signaling through P-selectin glycoprotein ligand-1 (PSGL-1)/Akt/mTOR that
189 minus of the leukocyte cell-surface molecule P-selectin glycoprotein ligand-1 (PSGL-1, CD162) are imp
190 ar adhesion molecule-1 (ICAM-1, CD54), CD44, P-selectin glycoprotein ligand-1 (PSGL-1, CD162), cytoki
191 gulant microparticles in human blood through P-selectin glycoprotein ligand-1 (PSGL-1; encoded by the
192 inistration of a recombinant soluble form of P-selectin glycoprotein ligand-1 (PSGL-1; the recombinan
193 on in vivo and on P-selectin in vitro, where P-selectin-glycoprotein-ligand-1 (PSGL-1) is found in di
194 eously express functional rolling machinery (P-selectin glycoprotein ligand-1 [PSGL-1] and Sialyl-Lew
196 to mouse neutrophils, this was dependent on P-selectin glycoprotein ligand 1 (PSGL1), alpha(L)beta(2
197 erized by a Bcl6-dependent downregulation of P-selectin glycoprotein ligand 1 (PSGL1, a CCL19- and CC
198 ced synthesis of C2-O-sLe(x) associated with P-selectin glycoprotein ligand-1, reduced cell tethering
199 d the lifetimes of P-selectin complexes with P-selectin glycoprotein ligand-1, revealing both catch a
200 teraction with its leukocyte ligand, PSGL-1 (P-selectin glycoprotein ligand 1), the interaction with
201 cking molecules, including CCR9, L selectin, P selectin glycoprotein ligand-1, the integrin subunits
202 singly, however, donor T cells deficient for P-selectin glycoprotein ligand 1, the most well describe
203 y use multiple P-selectin ligands apart from P-selectin glycoprotein ligand 1 to interact with P-sele
204 nd that eosinophils and neutrophils both use P-selectin glycoprotein ligand-1 to form stable conjugat
205 trafficking is dependent upon the binding of P-selectin glycoprotein ligand-1 to P- and E-selectin on
206 amed endothelium in vivo and cooperates with P-selectin glycoprotein ligand-1 to recruit neutrophils
207 t caNFATc1 enhances expression of functional P-selectin glycoprotein ligand-1, up-regulates Fas ligan
208 Tregs, forming the Sialyl Lewis X moiety on P-selectin glycoprotein ligand-1, would improve their tr
WebLSDに未収録の専門用語(用法)は "新規対訳" から投稿できます。